Supernus Pharmaceuticals, Inc.
SUPN· Nasdaq
SUPNSupernus Pharmaceuticals, Inc.
Filed Mar 21, 2014 · 10-K · 80 days after period end · 0001047469-14-002791
| Metric | Q4 2013 | Q4 2012 | Q4 2011 |
|---|---|---|---|
| Revenue | $10.33M | $1.09M | $42.00K |
| Net Income | -$22.41M | -$13.51M | $81.98M |
| EPS Diluted | -$0.65 | -$0.51 | $2.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Supernus Pharmaceuticals, Inc. · CIK 1356576 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Mar 21, 2014 · 80 d after period end
